Correction to: GWAS and Replication Analysis of Apparent Treatment-Resistant Hypertension

Joseph E. Ebinger(Cedars-Sinai Medical Center), Teemu J. Niiranen, Sandy Joung(Cedars-Sinai Smidt Heart Institute), Felix Vaura, Susan Cheng, Paul Hage(University of Southern California), Anni Kauko(University of Turku), FinnGen, Johan Sundström(Uppsala University)

Hypertension

June 17, 2026

10.1161/hyp.0000000000000265

Cited by 0

Related Papers

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

|The Lancet|2021|3.8k

Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data

|BMJ|2014|677

Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community

|Circulation|2009|414

Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study

|The Lancet Regional Health - Europe|2022|315

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden

|Clinical Epidemiology|2021|267